Genetic Testing and Fertility Counseling
Genetic Testing and Counseling
Our goal is to provide you with the information and support you need to make informed decisions on your journey to parenthood.
At RGI, we understand that starting a family can be a complex and emotional journey. That's why we offer a range of genetic testing and counseling services to help couples make informed decisions about their fertility and their future children's health.
Genetic Testing
Opting for Genetic Carrier screening and Preimplantation Genetic Testing (PGT) can equip you with valuable insights, empowering you to make informed decisions.
Counseling Services
Genetic Counselors are available through our Genetic Testing Lab, are available to provide personalized support and guidance throughout the testing process. They will work with you to understand your risk factors, answer any questions you may have, and help you make informed decisions about your fertility and your future children's health.
Costs and Insurance
The cost of genetic testing and counseling can vary depending on the type of test and your insurance coverage. Our financial counselors will work with you to understand the costs associated with genetic testing and counseling and help you navigate any insurance coverage you may have.
Genetic Carrier Screening
Genetic carrier screening is a type of genetic testing that is used to identify individuals who carry a genetic mutation that can cause a specific inherited disorder. This test is usually offered to couples pursuing IVF or to individuals who have a family history of a specific genetic disorder. The test is designed to identify individuals who carry a genetic mutation for a specific disorder, such as cystic fibrosis, Tay-Sachs, or sickle cell anemia, even if they do not have symptoms of the disorder themselves.
Why is Genetic Carrier Screening Important?
Carrier screening can help couples understand their risk of passing on a genetic disorder to their children. It can also identify individuals who are at risk of developing a disorder themselves, and they can take steps to manage or prevent it. This can help couples make informed decisions about their family planning and give them peace of mind.
How is Genetic Carrier Screening Performed?
The screening process typically involves a blood or saliva test, which analyzes the individual's DNA for specific genetic mutations associated with the disorder in question. The test results are usually available within 2 weeks.
Preimplantation Genetic Testing for Aneuploidies (PGT-A)
PGT-A is a test used to identify chromosomal abnormalities in embryos before they are implanted during an IVF cycle. This test can help couples reduce the risk of having a baby with chromosomal disorders, such as Down Syndrome, Turner Syndrome, or other chromosomal abnormalities. It can also be used for couples who have had recurrent pregnancy loss.
PGT-A allows patients and their physicians to select the healthiest embryo for transfer increasing chance of a successful pregnancy and a healthy baby.
PGT-A FAQ
The cost of PGT-A can vary depending on the location, the clinic, and the type of insurance coverage you have. According to the American Society for Reproductive Medicine, the average cost of PGT-A is between $4,000 - $5,000. However, it's important to note that this cost can be higher or lower depending on the specific circumstances. It's best to check with the clinic you're considering and your insurance provider for an accurate estimate of the cost of PGT-A, as well as any financing options available.
PGT-A is considered a safe procedure, with a low risk of complications. However, as with any medical procedure, there is a small risk of harm to the embryo or pregnancy loss. It's important to discuss the potential risks and benefits of PGT-A with your doctor.
PGT-A offers several advantages, including the ability to identify chromosomal abnormalities in embryos, which can improve the chances of having a healthy baby. It can also help couples who have had recurrent pregnancy loss by identifying and avoiding embryos with chromosomal abnormalities.
During an IVF cycle, a small number of cells are removed from the developing embryos and then undergo chromosomal analysis. This can be done through a technique called trophectoderm biopsy, where a small number of cells are removed from the outer layer of the embryo.
Preimplantation Genetic Testing for Aneuploidies (PGT-A) is a type of genetic testing used to identify chromosomal abnormalities in embryos. It helps couples reduce the risk of having a baby with chromosomal disorders, such as Down Syndrome, Turner Syndrome, or other chromosomal abnormalities. PGT-A can also be beneficial for those have experienced recurrent pregnancy loss.
Preimplantation Genetic Testing for Monogenic/Single Gene Disorders (PGT-M)
Preimplantation Genetic Testing for Monogenic/Single Gene Disorders or PGT-M is a test that is used to identify specific genetic disorders caused by mutations in a single gene. This test can help couples who are at risk of passing on a specific inherited genetic disorder such as cystic fibrosis, Tay-Sachs, or sickle cell anemia.
PGT-M FAQ
The cost of PGT-M can vary depending on the type of test and the location of the clinic. It's best to check with the clinic you're considering and your insurance provider for an accurate estimate of the cost of PGT-M, as well as any financing options available.
PGT-M is considered a safe procedure, with a low risk of complications. However, as with any medical procedure, there is a small risk of harm to the embryo or pregnancy loss. It's important to discuss the potential risks and benefits of PGT-M with your doctor.
PGT-M offers several advantages, including the ability to identify specific genetic disorders caused by mutations in a single gene. This can help couples who are at risk of passing on a specific inherited genetic disorder to make informed decisions about their family planning.
During an IVF cycle, a small number of cells are removed from the developing embryos and then undergo genetic analysis. Trophectoderm biopsy is a common method for obtaining cells for PGT-M analysis.
Trophectoderm biopsy involves removing a few cells from the outer layer of the embryo, which will eventually develop into the placenta. The biopsy is usually performed on day 5 or 6 after fertilization, when the embryo has reached the blastocyst stage.